SOURCE: MMRGlobal, Inc.

MMRGlobal, Inc.

August 04, 2011 09:58 ET

MMRGlobal Stimulus Program Available to All Health Care Professionals Including Surgery and Weight Loss Centers

LOS ANGELES, CA--(Marketwire - Aug 4, 2011) - MMRGlobal, Inc. (OTCBB: MMRF) ("MMR") a provider of Personal Health Records (PHR) through its MyMedicalRecords.com portal and electronic document management systems for health care professionals (www.mmrprovideos.com), today announced a nationwide program offering health care practices the opportunity to participate in the MMR Stimulus Program by distributing specially branded brochures to patients at no cost to the practice. A sample of the brochure can be seen at http://pv.mmrcontent.com/PatientViewFlipBook/.

The program enables health care professionals to generate unlimited MMR stimulus money, which can easily be many times greater than programs offered by the government that go up to $44,000 over a five-year period of time (http://video.mmrcontent.com/pro_teaser/). Any health care professional, including dentists, veterinarians and homeopathic specialists, can offer their patients a 30-day free trial of the premier MyMedicalRecords.com Personal Health Record (www.mmrvideos.com). If the patient upgrades to the full-featured account, the doctor receives 25% of the monthly subscriber fees in the first year and ongoing residuals for as long as the account is maintained. Payments are designed to reimburse the costs of helping health care professionals set up and update a patient's PHR, reducing the cost of communicating with patients.

Residuals are designed to cover the costs of helping the patients set up and maintain their PHRs, reducing the cost of communicating with patients.

The program enables doctors to begin the process of easing their way into the electronic health records mandate at no cost while providing Personal Health Records to all patients well in advance of the 2014 target.

According to Robert H. Lorsch, MMRGlobal CEO, "Offering a Personal Health Record program that involves no cost to the health care professional demonstrates a commitment to responsibility and a special concern for patient safety and care. In the same manner that a dentist offers a toothbrush, or a pediatrician a lollipop, it is rewarding to encourage patients to participate in their safety and care, as well as potential cost savings, by setting up a PHR."

The Company plans on announcing a major test program with inbound call centers that do patient referrals to surgery centers and physicians and upsells to weight loss product and services companies.

About MMRGlobal, Inc.

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc. ("MMR"), provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. The Company's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients in real time through an integrated patient portal. MMR is an Independent Software Vendor Partner with Kodak to deliver an integrated turnkey EMR solution for health care professionals. Through its merger with Favrille, Inc. in January 2009, the Company acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. and its products, visit www.mmrglobal.com.

Forward-Looking Statements

Any statements contained in this press release that refer to future events or other non-historical matters are forward-looking statements, and some can be identified by the use of words (and their derivations) such as "need," "possibility," "offer," "development," "if," "negotiate," "when," "begun," "believe," "achieve," "will," "estimate," "expect," "maintain," "plan," "help" and "continue," or the negative of such terms and other comparable terminology. MMRGlobal, Inc. disclaims any intent or obligation to revise or update any forward-looking statements. These forward-looking statements implied or expressed are based on MMRGlobal, Inc.'s reasonable expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The information discussed in this release is subject to various risks and uncertainties related but not limited to changes in MMRGlobal, Inc.'s business prospects, its results of operations or financial condition, the current uncertainty and instability in financial and lending markets, including global economic uncertainties, acceptance of the MMR Stimulus Program, marketing promotions and campaigns, product integration in physician practices and hospitals, timing and volume of sales and installations, length of sales cycles and the installation process, competitive product offerings and promotions, risks related to third party vendors, government regulation and changes in health care initiatives, and such other risks and uncertainties as detailed from time to time in MMRGlobal, Inc.'s public filings with the U.S. Securities and Exchange Commission.

Contact Information